MRI Perfusion Equals FFR for Coronary Disease Evaluation
|
By MedImaging International staff writers Posted on 03 Jul 2019 |
A new study shows that non-invasive magnetic resonance imaging (MRI) measurement of cardiac blood flow is on par with cardiac catheterization.
Researchers at Goethe University Hospital (KGU; Frankfurt am Main, Germany), National University of Singapore (NUS, Singapore), the University of Leeds (United Kingdom), and other institutions conducted a multicenter, clinical-effectiveness trial to examine if a cardiovascular MRI–based strategy is non-inferior to an fractional flow reserve (FFR) cardiac catheterization angiography based strategy, with respect to major adverse cardiac events. The study included 918 patients with typical angina to a cardiovascular MRI–based strategy or an FFR-based strategy.
Revascularization was recommended for patients in the cardiovascular-MRI group with ischemia in at least 6% of the myocardium, or in the FFR group with an FFR of 0.8 or less. The composite primary outcome was death, nonfatal myocardial infarction (MI), or target-vessel revascularization within one year. The results revealed that in the MRI group, only 36% required a diagnostic cardiac catheterization and vascular dilation, compared to the FFR group (45 %). Importantly, the two groups did not differ in terms of continuing symptoms, the development of new symptoms, complications, or death. The study was published on June 20, 2019, in the New England Journal of Medicine (NEJM).
“Patients with stable chest pains who previously would have received cardiac catheterization can alternatively be examined with MRI,” concluded lead author Professor Eike Nagel, MD, of KGU. “The results for the patients are just as good, but an examination by MRI has many advantages: the procedure takes about 40 minutes, patients merely receive a small cannula in their arm, and are not subject to radiation.”
FFR is a physiological index used to determine the hemodynamic severity of atherosclerotic narrowing of the coronary arteries. It specifically identifies which coronary narrowing is responsible for the ischemic obstruction of the flow of blood to a patient’s heart muscle, and helps guide interventional cardiologists in determining which lesions warrant stenting, resulting in improved patient outcomes and reduced health care costs.
Related Links:
Goethe University Hospital
National University of Singapore
University of Leeds
Researchers at Goethe University Hospital (KGU; Frankfurt am Main, Germany), National University of Singapore (NUS, Singapore), the University of Leeds (United Kingdom), and other institutions conducted a multicenter, clinical-effectiveness trial to examine if a cardiovascular MRI–based strategy is non-inferior to an fractional flow reserve (FFR) cardiac catheterization angiography based strategy, with respect to major adverse cardiac events. The study included 918 patients with typical angina to a cardiovascular MRI–based strategy or an FFR-based strategy.
Revascularization was recommended for patients in the cardiovascular-MRI group with ischemia in at least 6% of the myocardium, or in the FFR group with an FFR of 0.8 or less. The composite primary outcome was death, nonfatal myocardial infarction (MI), or target-vessel revascularization within one year. The results revealed that in the MRI group, only 36% required a diagnostic cardiac catheterization and vascular dilation, compared to the FFR group (45 %). Importantly, the two groups did not differ in terms of continuing symptoms, the development of new symptoms, complications, or death. The study was published on June 20, 2019, in the New England Journal of Medicine (NEJM).
“Patients with stable chest pains who previously would have received cardiac catheterization can alternatively be examined with MRI,” concluded lead author Professor Eike Nagel, MD, of KGU. “The results for the patients are just as good, but an examination by MRI has many advantages: the procedure takes about 40 minutes, patients merely receive a small cannula in their arm, and are not subject to radiation.”
FFR is a physiological index used to determine the hemodynamic severity of atherosclerotic narrowing of the coronary arteries. It specifically identifies which coronary narrowing is responsible for the ischemic obstruction of the flow of blood to a patient’s heart muscle, and helps guide interventional cardiologists in determining which lesions warrant stenting, resulting in improved patient outcomes and reduced health care costs.
Related Links:
Goethe University Hospital
National University of Singapore
University of Leeds
Latest MRI News
- New Material Boosts MRI Image Quality
- AI Model Reads and Diagnoses Brain MRI in Seconds
- MRI Scan Breakthrough to Help Avoid Risky Invasive Tests for Heart Patients
- MRI Scans Reveal Signature Patterns of Brain Activity to Predict Recovery from TBI
- Novel Imaging Approach to Improve Treatment for Spinal Cord Injuries
- AI-Assisted Model Enhances MRI Heart Scans
- AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
- New MRI Technique Reveals Hidden Heart Issues
- Shorter MRI Exam Effectively Detects Cancer in Dense Breasts
- MRI to Replace Painful Spinal Tap for Faster MS Diagnosis
- MRI Scans Can Identify Cardiovascular Disease Ten Years in Advance
- Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable
- Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
- New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes
- AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
- AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Channels
Radiography
view channel
Routine Mammograms Could Predict Future Cardiovascular Disease in Women
Mammograms are widely used to screen for breast cancer, but they may also contain overlooked clues about cardiovascular health. Calcium deposits in the arteries of the breast signal stiffening blood vessels,... Read more
AI Detects Early Signs of Aging from Chest X-Rays
Chronological age does not always reflect how fast the body is truly aging, and current biological age tests often rely on DNA-based markers that may miss early organ-level decline. Detecting subtle, age-related... Read moreUltrasound
view channel
Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
Ultrasound imaging depends on a conductive gel to eliminate air between the probe and the skin so sound waves can pass clearly into the body. While the imaging technology is fast, safe, and noninvasive,... Read more
AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
Placenta accreta spectrum (PAS) is a life-threatening pregnancy complication in which the placenta abnormally attaches to the uterine wall. The condition is a leading cause of maternal mortality and morbidity... Read moreNuclear Medicine
view channel
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
Targeted cancer therapies can be highly effective, but only when a patient’s tumor expresses the specific protein the treatment is designed to attack. Determining this usually requires biopsies or advanced... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







